Value in Health Publication Summary

A groundbreaking study by Carevive sheds light on the immense potential of Carevive SMART Data in transforming cancer care, even amidst a global pandemic. Enrolling 282 patients, the study achieved an impressive 88% survey completion rate, revealing vital patient insights.

Results indicated that patients reported severe symptoms 54% of the time. However, with the support of their care teams, these symptoms were effectively managed through self-management instructions and timely phone calls, leading to a decrease in symptom severity.

The study showcased the feasibility and acceptance of collecting Patient-Reported Outcomes (PROs) during challenging times. Validated instruments played a crucial role in improving and benchmarking patient outcomes.

Together, let’s build a brighter future for cancer management and patient well-being.

Recent Episodes

Sterile processing teams are under constant pressure—handling growing surgical demands, working short-staffed, and navigating strict regulations—so getting every instrument tray assembled right the first time has never mattered more. Even a single assembly error can cascade into costly OR delays or, worse, compromise patient safety. Recent research highlights that most surgical instrument errors stem from…

Obstructive sleep apnea affects a whopping 30 million Americans, yet millions remain undiagnosed or abandon CPAP therapy due to its discomfort and inconvenience. Recent innovations in oral appliance therapy, however, are opening up new possibilities for patients seeking safe, effective, and lasting solutions. With sleep apnea linked to virtually every chronic disease—from heart disease to…

In this bonus Career Journeys episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims, Chief Marketing Officer of TruMerit, welcomes Jose Arnold Tariga, Director of Clinical Education and Development at Insight Global Health and one of the Top 10 finalists for the prestigious Aster Guardians Global Nursing Award, selected from more…